BioArctic Sweden

FDA approves LEQEMBI™ under the Accelerated Approval pathway for the treatment of Alzheimer's disease

View original content:https://www.prnewswire.co.uk/news-releases/fda-approves-leqembi-lecanemab-irmb-under-the-accelerated-approval-pathway-for-the-treatment-of-alzheimers-disease-301716133.html